Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Aspirin to prevent cardiovascular events in patients with community-acquired pneumonia or influenza
2023-504553-12-01Phase 4Completed
- Sponsor
- Amsterdam University Medical Center
- Start
- Sep 2023
- Modality
- Orthosteric Ligands → Classical Binding Small Molecules → Small Molecules
- Countries
- 1
01
Overview
Phase 4, randomised, double-blind trial in pneumonia, influenza, myocardial infarction (MI) and 2 more comparing Aspirin + pantoprazole with Placebo + pantoprazole (2 arms). Primary endpoint: Incidence of an acute coronary syndrome (ACS). Started Sep 2023; status: completed.
02
Drugs
aspirin
03
Conditions
pneumoniainfluenzamyocardial infarction (MI)acute coronary syndrome (ACS)cardiac morbidity
Beyond the preview
Go deeper on 2023-504553-12-01.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2023-504553-12-01.